# Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)

> **NCT02051023** · PHASE3 · COMPLETED · sponsor: **Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA** · enrollment: 41 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** FML 0.1% eyedrops
- **DRUG:** Liquifilm artificial tears eyedrops

## Key facts

- **NCT ID:** NCT02051023
- **Lead sponsor:** Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2015-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02051023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02051023, "Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02051023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*